Related Experiment Videos
[Comparison of the bioequivalence of two allopurinol preparations]
K Bührens1, P Berndt, C M Hilgenstock
1McKnight Laboratories, Hamburg.
Arzneimittel-Forschung
|March 1, 1991
Abstract:
Allopurinol generally is considered to be a problematic substance as to its bioavailability. To prove the quality, the in-vivo bioequivalence of an allopurinol (CAS 315-30-0) preparation (Cellidrin 300) in comparison to the standard preparation has been investigated. Both products were bioequivalent with regard to all relevant parameters such as AUC, tmax and Cmax.